Risk of subclinical atrial fibrillation in patients with cardiac implantable electronic devices after COVID-19 infectio

Completed

• Conditions: Risk of subclinical atrial fibrillation after COVID-19 infection.; subclinical atrial fibrillation; pacemakers; defibrillators; post-COVID-19; long COVID-19

• Registration Number: TCTR20230324004
• Lead Sponsor: o funding source.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-03-24
• Study Completion: 2023-11-09
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 132

Inclusion Criteria

Patients with cardiac implantable electronic devices (CIEDs) having atrial leads.

Exclusion Criteria

1. Patients with previous cardiac surgery.
2. Patients with atrial fibrillation, atrial flutter or atrial tachycardia documenting from 12-lead ECG.
3. Patients with thyrotoxicosis, sepsis, electrolyte abnormalities, ESRD including renal replacement therapy.
4. Pregnant patients
5. Patients participating other concealed study.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Rate of subclinical atrial fibrillation Six months after COVID-19 infection. Rate of subclinical atrial fibrillation from device interrogation

Secondary Outcome Measures

Name	Time	Method
/A N/A N/A